Azd-4547

ACH, BBDS, BEK, BEK fibroblast growth factor receptor, BFGFR, BFR1, Basic fibroblast growth factor receptor 1, CD 333, CD 334, CD309, CD309 antigen, CD331, CD332, CD332 antigen, CD333 antigen, CD334 antigen, CEK, CEK 2, CEK3, CFD1, Craniofacial dysostosis 1, EC 2.7.10.1, ECT1, FGF receptor, FGFBR, FGFR1/PLAG1 fusion, FGFR1_HUMAN, FGFR2_HUMAN, FGFR3_HUMAN, FGFR4_HUMAN, FLG, FLK-1, FLK1, mouse, homolog of, FLT-2, Fetal liver kinase 1, Fibroblast growth factor receptor 2, Fibroblast growth factor receptor 3, Fibroblast growth factor receptor 3 (achondroplasia thanatophoric dwarfism), Fibroblast growth factor receptor 4, Fms-like gene, Fms-like tyrosine kinase 2, HBGFR, HH2, HRTFDS, HSFGFR3EX, JTK 2, JTK 4, JWS, Jackson Weiss syndrome, K-sam, KAL2, KGFR, KRD1, Kdr, Keratinocyte growth factor receptor, Keratinocyte growth factor receptor 2, Kinase insert domain receptor, Kinase insert domain receptor (a type III receptor tyrosine kinase), Ly73, MFR 3, MGC20292, N-SAM, OGD, Protein tyrosine kinase, Protein-tyrosine kinase receptor flk-1, Proto-oncogene c-Fgr, SAM 3, TK14, TK25, TKF, Tyrosine kinase JTK 4, Tyrosine kinase growth factor receptor, Tyrosine kinase related to fibroblast growth factor receptor, Tyrosylprotein kinase, VEGFR, VEGFR-2, VGFR2_HUMAN, Vascular endothelial growth factor receptor 2, Z FGFR 3, bFGF-R-1, bacteria-expressed kinase, fc13h 10, fibroblast growth factor receptor 1, fms-related tyrosine kinase 2, heparin-binding growth factor receptor, hydroxyaryl-protein kinase, protein tyrosine kinase, receptor like 14, soluble FGFR4 variant 4, soluble VEGFR2

Biochemicals